Analysis of MDMA and Ketamine sample seizures in Taiwan

Taiwan Journal of Public Health

Volumn 24, Issue 3, 2005, Pages 264-273

  Chuang, Shu Fen ^a   Wu, Shou Chien ^a   Tsay, Wen Ing ^a   Li, Jin Heng ^a   Liu, Ray H ^b,c   Liu, Ju Tsung ^d   Lee, Tien Chun ^e   Yang, Yi Ta ^f   Sun, Main Ping ^g  

^a Executive Yuan   (Taiwan)

^b FOOYIN UNIVERSITY   (Taiwan)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d MINISTRY OF NATIONAL DEFENSE   (Taiwan)

^e MINISTRY OF JUSTICE   (Taiwan)

^f ARCHITECTURE AND BUILDING RESEARCH INSTITUTE   (Taiwan)

^g Taipei City Police Department   (Taiwan)

Author keywords

Arrested; DMMDA; Ketamine; MDMA

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; BENZENE DERIVATIVE; BENZYLAMINE DERIVATIVE; CAFFEINE; CANNABIS; CARBENOID; DIAZEPAM; EPHEDRINE; ESTAZOLAM; FLUNITRAZEPAM; KETAMINE; LIDOCAINE; METHAMPHETAMINE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; N METHYL 1 (3,4 METHYLENEDIOXY)BENZYLAMINE; N METHYL 1 (3,4 METHYLENEDIOXYPHENYL) 2 BUTANAMINE; NIMETAZEPAM; NOREPHEDRINE; PARACETAMOL; PHENOBARBITAL; PIPERONAL 3,4 METHYLENEDIOXYPHENYL 2 PROPANOL; PSEUDOEPHEDRINE; TRAMADOL; UNCLASSIFIED DRUG;

ARTICLE; DRUG ABUSE; HUMAN; JURISPRUDENCE; POLICE; TABLET; TAIWAN;

EID: 24744459440     PISSN: 10232141     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Stein D. The use of heliotrope oil as a precursor source for piperonal. J Clan Lab Invest Chem 1996;6:17-8.
2. Drug Enforcement Adiministration. Uncommon precursor Sources used in 3,4-methylenedioxymethamphetamine (MDMA). Microgram 1999;32:193-4.
3. Poortman A. Unusual manufactureing of MDMA in The Netherlands. J Clan Lab Invest Chem 1998;8:25-6.
4. Laing RR, Dawson B. Identification of the major product from the Ritter reaction using safrole . J Clan Lab Invest Chem 1997;7:22-6.
5. Renton RJ, Cowie JS, Oon MCH. A Study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethamphetamine and its application to forensic drug analysis. Forensic Sci Int 1993;60:189-202.
6. Lock E. Impurities found in MDMA and MDEA street samples: synthesis, identification and interpretation. Proceedings of the ENFSI 1st European Meeting of Forensic Science. Switzerland, 1997;17-9.
7. Verweij AMA. Impurities in Illicit drug preparations: 3,4-(methylenedioxy)amphetamine and 3,4-(methylenedioxy)methamphetamine. Forensic Sci Rev 1992;4:137-46.
8. Dal Carson TA. An evaluation of the potential for clandestine manufacture of 3,4-(methylenedioxy) amphetamine(MDA)analoys and homologs. J Forensic Sci 1990;34:675-97.
9. O'Connell D, Haffron JJA. Rapid analysis of illicit drugs by mass spectrometry: results from seizures in Ireland. Analyst 2000;125:119.
10. Mikami T, Naruse N, Fukura Y, et al. Determining vulnerability to schizophrenia in methamphetamine psychosis using exploratory eye movements. Psychiat Clin Neuros 2003;57:433-40.
11. Matsushima E, Kojima T, Ohta K, et al. Exploratory eye movement dysfunctions in patients with schizophrenia: possibility as a discriminator for schizophrenia. J Psychiat Res 1998;32:289-95.
12. Iwanami A, Kanamori R, Suga I, Kaneko T, Kamijima K. Reduced attention-related negative potentials in methamphetamine psychosis. J Nerv Ment Dis 1995;183:693-7.
13. Sato M, Numachi Y, Hamamura T. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophrenia Bull 1992;18:115-22.
14. Kojima T, Matsushima E, Nakajima K , et al. Eye movements in acute, chronic, and remitted schizophrenics. Biol Psychiat 1990;27:975-89.
15. Merck E. Verfahren zur darstellung von alkyloxyaryl-, dialyloxyary-, und alkylenedioxyaryaminopropanen, bzw. Deren armistickstoff monalkylierten derivaten. G P 1914;274:350.
16. URL:http://law.moj.gov.tw/scripts/query4.asp? B2= %AAu%A1@%A1@%AD%B2&FNAME=C0000008
17. (MDMA, 3,4-Methylened: oxymethamphefamine). 2004/5/10. URL: http://www.nbcd.gov.tw/prop/prop_1-08. asp
18. Rochester JA, Kirchner JT. Ecstasy (3,4-methylenedioxymethamphetamine): history, neurochemistry, and toxicology. J Am Board Fam Pract 1999;12:137-42.
19. Walubo A, Seger D. Fatal multi-organ failure after suicidal overdose with MDMA, 'ecstasy': case report and review of the literature. Hum Exp Toxicol 1999; 18:119-25.
20. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 2003;55:463-508.
21. Traub SJ, Hoffman RS, Nelson LS. The "ecstasy" hangover hyponatremia due to 3,4-methylenedioxymethamphetamine. J Urban Health 2002;79:549-55.
22. Gowing LR, Henry-Edwards SM, Irvine R, Ali RL. The health effects of ecstasy: a literature review. Drug Alcohol Rev 2002;21:53-63.
23. Smith KM, Larive LL, Romanelli F. Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate. Am J Health-Sys Ph 2002; 59:1067-76.
24. Teter CJ, Guthrie SK. A comprehensive review of MDMA and GHB: two common club drugs. Pharmacotherapy 2001;21:1486-513.
25. Freese TE, Miotto K, Reback CJ. The effects and consequences of selected club drugs. J Subst Abuse Treat 2002;23:151-6.
26. Micallef J, Tardieu S, Gentile S, et al. Effect of a sub-anaesthetic dose of letamine on emotional an behavioral state in healthy sufjects. Neurophysiol Clin 2003; 33:138-47.
27. Antoniou T, Tseng AL. Interactions between recreational drugs and antiretroviral agents. Ann Pharmacother 2002; 36:1598-613.
28. Vollenweider FX. Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research. Pharmacopsychiatry 1998;31(Suppl 2):92-103.
29. Altura BT, Altura BM. Effects of barbiturates, phencyclidine, ketamine and analogs on cerebral circulation and cerebrovascular muscle. Microcirc Endoth Lym 1984;1:169-84.
30. U.S. Department of Justice, Drug Enforcement Administration. Federal Register: July 13,1999 (Volume 64, Number 133). Placement of ketamine-into schedule III: Scheduling Actions-1999. (cited 2004 May 10) Available from: URL: http://www.deadiversion.usdoj. gov/fed_regs/sched_actions/1999/fr0713 .htm
31. U.S. Department of Justice, Drug Enforcement Administration. National Forensic Labortory Information System. Annual Report, 2001. Drug Cases Analyzed. (cited 2004 May 10) Available from: URL: http://www.deadiversion.usdoj.gov/ nflis/ 2001annual_rpt.pdf
32. DrugScope. United Kingdom National Report, 2001. Drug Cases Analyzed (cited 2004 May 10) Available from: URL: http://www.drugscope.org. uk/druginfo/drugsearch/ds-report-results.asp? file=\wip\11\3\007chapter5.html
33. European Monitaring Centre for Drugs and Drug Addiction. Annual Report 2003: the State of the Drugs Problem in the European Union and Norway Markets and availability: Markets-q(i). (cited 2004 May 10) Available from: URL: http://statistics.emcdda.eu. int/index.cfm?fuseaction=public.Content & nNodeID=5368&sLanguageISO=EN.
34. European Monitaring Centre for Drugs and Drug Addiction. Finland Nation Report, 2002. Drug Markets: Seizuares. (cited 2004 May 10) Available from: URL: http://www.emcdda.eu.int/index.cfm?fuseaction=public. Content&nNodel ID=435
35. European Monitaring Centre for Drugs and Drug Addiction. German National Report, 2002. Drug Markets: Seizures, (cited 2004 May 10) Available from: URL: http://www.emcdda.eu.int/index.cfm? fuseaction=public.Content&nNodel ID=435
36. European Monitaring Centre for Drugs and Drug Addiction. Annual Report 2003: the State of the Drugs problem in the European Union and Norway. Markets and availability: Markets-10(i). (cited 2004 May 10) Available from: URL: http://statistics.emcdda.euint/index.cfm?fuseaction=public. content& nNodelID=5370&sLanguageISD=EN
37. Cheng WC, Poon NL, Chan MF. Chemical profiling of 3, 4- 3,4-methylenedioxymethamphetamine(MDMA) tablets arrested in Hong Kong. J Forensic Sci 2003;48:1249-59.
38. Brenneisen RL. Pharmacology of flunitrazepam and other benzodiazepines. In: Salamone SJ ed. Benzodiazepines and GHB Detection and Pharmacology. Totowa, New Jersey: Humana Press, 2001;12.
39. Byrd LD, Standish LJ, Howell LL. Behavioral effects of phencyclidine and amphetamine alone and in combination with other drugs. Eur J Pharmacol 1987;144:331-41.
40. NIDA Community Epidemiology Work Group. Epidemic Trends in Drug Abuse volume 1. Division of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse. Maryland: US NIH, 2003.